Background Recent studies on renin-angiotensin system (RAS) inhibitors have reported a
reduced risk of Alzheimer's disease (AD). Nevertheless, the effect of RAS inhibitor type and …

A quantitative meta-analysis was performed to evaluate the association of renin-angiotensin
system blockade (RASB) use with the incidence of cognitive impairment of aging and …

Background The antihypertensive angiotensin receptor blockers (ARBs) and angiotensin-
converting enzyme inhibitors (ACE-Is) have similar indications and mechanisms of action …

Background: Anti-hypertensive medications may reduce the incidence of cognitive
disorders. This may be due to reasons beyond their pure hypotensive effect. This study …

Background: Although emerging evidence shows angiotensin-receptor blockers (ARBs) may
have a beneficial effect against Alzheimer's disease (AD), the association is not consistent …

Do angiotensin receptor blockers prevent Alzheimer's disease... : Current Opinion in
Cardiology Do angiotensin receptor blockers prevent Alzheimer's disease? : Current Opinion …

Some studies suggest that angiotensin II type 1 receptor blockers (ARBs) may protect
against memory decline more than angiotensin-converting enzyme inhibitors (ACE-Is), but …

The renin–angiotensin system (RAS) is involved in pathological mechanisms of target organ
damage as well as the induction of hypertension; therefore, blockade of the RAS has been …

Objective To evaluate the association of all RAAS inhibitors, ACE inhibitors (ACEIs) and
angiotensin II receptor blockers (ARBs) on dementia onset (any dementia, Alzheimer's …

Objective To evaluate the effects of renin-angiotensin system blockade (RASB) and its
classes on the incidences of cognitive decline and dementia. Methods PubMed, the …